Ethyl 1-(aminomethyl)cyclobutanecarboxylate, 95.0%, 250mg

5-[(3,5-dimethylphenoxy)methyl]-4-methyl-4H-1,2,4-triazole-3-thiol, 95.0%, 5g

3-Ethoxy-5-methylpyridine, 95+%, 1g

Colonna capillare per GC ROTI®Cap-1, 50 m, 0,32 mm, 0,10 µm, 1 Pezzo(i)

Diethylene Glycol Monovinyl Ether (stabilized with KOH)>96.0%(GC)100mL

2-(2-Bromophenyl)-2-methylpropanenitrile, 95.0%, 5g

Difluoroacetaldehyde ethyl hemiacetal, 90.0%, 1g

Methyl 3-amino-2-fluorobenzoate, 95.0%, 5g

2,4,6-Triisopropylbenzenesulfonohydrazide, 95.0%, 10g

Methyl 4-amino-2-(trifluoromethyl)benzoate, 98%, 25g

4-[methyl(phenyl)sulfamoyl]benzoic acid, 97%, 100mg

(3R,4S)-4-(2-Cyclopropylethyl)-3-(methoxymethoxy)-1-(4-methoxyphenyl)azetidin-2-one, 98%, 100mg

Piperazine, 1-(6-bromo-3-pyridinyl)-, 95.0%, 1g